NET PROFIT (x1000 SEK)
EMPLOYEES
Biomediq A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-100
|
-86
|
-36 |
| Total assets |
62
|
177
|
338 |
| Current assets |
62
|
177
|
338 |
| Current liabilities |
65
|
70
|
79 |
| Equity capital |
-3
|
80
|
169 |
| - share capital |
616
|
596
|
599 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-4.8%
|
45.2%
|
50.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
95.4%
|
252.9%
|
427.8% |
| Return on equity (ROE) |
3333.3%
|
-107.5%
|
-21.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.